Enhancing hERG Risk Assessment with Interpretable Classificatory and Regression Models

Igor H Sanches1,2,3, Rodolpho C Braga4, Vinicius M Alves5

  • 1Laboratory for Molecular Modeling and Drug Design (LabMol), Faculty of Pharmacy, Universidade Federal de Goiás, Goiânia, GO 74690-900, Brazil.

Insights

This study enhances Pred-hERG 5.0, a tool for predicting human Ether-à-go-go-Related Gene (hERG) channel blockage, offering cost-effective, reliable cardiotoxicity assessment. The improved tool provides accurate predictions and visual explanations for drug safety evaluations.

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Drug discovery

Background:

  • The human Ether-à-go-go-Related Gene (hERG) channel is crucial for cardiac action potential; its inhibition causes potentially fatal cardiotoxicity.
  • Current in vitro methods for identifying hERG blockers are costly, necessitating the development of alternative, cost-effective predictive tools.

Purpose of the Study:

  • To enhance the Pred-hERG tool for predicting hERG blockage by developing advanced Quantitative Structure-Activity Relationship (QSAR) models.
  • To improve early-stage assessment of drug-induced cardiotoxicity through more accurate and interpretable predictive models.

Main Methods:

  • Developed new QSAR models incorporating updated data from ChEMBL v30 (14,364 compounds).
  • Updated existing binary and multiclassification models and introduced new regression models for predicting hERG activity (pIC50).
  • Integrated SHAP (SHapley Additive exPlanations) values for model interpretability and implemented explainable AI (XAI).

Main Results:

  • New binary and multiclassification models demonstrated superior performance compared to previous Pred-hERG versions and other public models.
  • The optimal regression model achieved an R² of 0.61 and an RMSE of 0.48, outperforming existing literature models.
  • Pred-hERG 5.0 provides classification, multiclassification, regression predictions, probability maps, and SHAP value visualizations.

Conclusions:

  • Pred-hERG 5.0 offers a user-friendly, reliable platform for early cardiotoxicity assessment via hERG blockage prediction.
  • The tool's enhanced predictive accuracy and explainability support informed decision-making in drug development.
  • Accessible to users without computational expertise, Pred-hERG 5.0 is freely available for broader research application.

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
114
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
80